cannabigerol (CBG) / CNBX Pharma - LARVOL DELTA

Cannabics Pharmaceuticals study shows cannabinoids CBC and CBG exhibit anti-tumor properties on gastrointestinal cancer cells (PRNewswire) - "Cannabics Pharmaceuticals Inc...announced today that in a series of tests conducted at the company's High Through-put Screening (HTS) facility in Israel, it has been shown that the cannabinoids CBC (Cannabichromene) and CBG (Cannabigerol) both exhibit anti-tumor properties, tested on human Gastrointestinal Cancer Cells...CBC and CBG were both shown to induce significantly higher rates of necrosis in these cancer cells compared to other cannabinoids, thus strengthening previously obtained results."

Clinical data

Cannabics Pharmaceuticals announces cannabigerol (CBG) shown to have anti-tumor properties (PRNewswire) - "Cannabics Pharmaceuticals Inc...announced....that in a pre-clinical study held at the company's High Throughput Screening (HTS) lab facilities in Israel, preliminary findings show that the cannabinoid Cannabigerol (CBG) was shown to have a greater anti-tumor effect on human stomach and bone cancer cell lines compared to CBGA, the acidic form of the compound."

Preclinical